"The bench is easy" and George Church's other wisdom-STAT

2021-12-13 10:04:36 By : Ms. Enya Zhang

Exclusive analysis in biotechnology, pharmaceuticals and life sciences

In-depth analysis of biotechnology, pharmaceuticals and life sciences

Some of the most trusted and well-connected reporters from the U.S. industry

Join STAT+ reporters and leading industry experts in our STAT+ dialogue series

Hosted by STAT+, as well as early access and discounts at industry events across the country

Sent to your inbox to give you a brief introduction to the most important industry news of the day

Just like our CRISPR Trackr and Drug Pricing Policy Tracker

In-depth analysis of biotechnology, pharmaceuticals and life sciences

Some of the most trusted and well-connected reporters from the U.S. industry

Join STAT+ reporters and leading industry experts in our STAT+ dialogue series

Hosted by STAT+, as well as early access and discounts at industry events across the country

Sent to your inbox to give you a brief introduction to the most important industry news of the day

Just like our CRISPR Trackr and Drug Pricing Policy Tracker

George Church was a great Harvard biologist. He pioneered DNA sequencing and gene editing, and was known for his bold bets. He has founded more than 30 companies, including companies that promise to use hardy elephants to curb climate change, use dating apps to end genetic diseases, and use blockchain to keep your DNA away from hackers.

What is behind his boldness? During the STAT Summit in 2021, Church said in a conversation with STAT senior medical writer Matthew Hepper that "open minded". "One of the reasons people miscalculate is the index."

Unlock this article by subscribing to STAT+ and enjoy the first 30 days for free!

STAT+ is STAT's premium subscription service for in-depth biotechnology, pharmaceutical, policy, and life science reporting and analysis. Our award-winning team covers Wall Street news, Washington policy developments, early scientific breakthroughs and clinical trial results, as well as healthcare disruptions in Silicon Valley and beyond.

Megan Molteni is a scientific writer for STAT, covering genomic medicine, neuroscience, and reproductive technology.

This name will be displayed with your comment

There was an error saving your display name. Please check and try again.

Authors: Adam Feuerstein and Damian Garde

Reports from the frontiers of health and medicine